Conclusions: The MoCA is a valid estimate of daily life functional autonomy in non-demented PD patients, also reflecting apathetic features of a dysexecutive nature. It assesses different cognitive domains: attention and concentration, executive functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and orientation. Results: MoCA scores were significantly associated with the SES ( r s(73) = 0.34 p = 0.005) and the DAS-Executive ( r(67) = −0.47 p < 0.001), while not to other FI/BP outcomes and QoL measures. The Montreal Cognitive Assessment (MoCA) was designed as a rapid screening instrument for mild cognitive dysfunction. Intake of psychotropic drugs was also covaried when assessing the association between the MoCA and BP/QoL measures. Associations of interest against FI, QoL, and BP outcomes were tested via Bonferroni-corrected Pearson’s/Spearman’s correlations while covarying for demographics, disease duration as well as UPDRS-III, UPDRS-IV, and HY scores. Evidence-informed geriatric assessment tools in the Try This: Series of assessments (cost-free, web-based resources. It is easy to administer and score, and the results can be interpreted by the. Methods: Seventy-four non-demented PD patients were administered the MoCA and underwent motor functional – i.e., Unified Parkinson’s Disease Rating Scale (UPDRS), Modified Hoehn-Yahr Scale (HY), and Schwab and England Scale (SES) –, behavioural and psychological – i.e., State- and Trait-Anxiety Inventory-Form Y (STAI-Y1/-Y2), Beck Depression Inventory (BDI), and Dimensional Apathy Scale (DAS) – and QoL evaluations – i.e., MOS 36-Item Short Form Health Survey (SF-36). The Montreal Cognitive Assessment is a quick and easy instrument that can be adapted for use in the clinical setting. Objectives: The objective of this study was to examine, within an Italian cohort of non-demented Parkinson’s disease (PD) patients, the ecological validity of the Montreal Cognitive Assessment (MoCA) by assessing its association with (1) functional independence (FI), (2) quality of life (QoL), and (3) behavioural-psychological (BP) outcomes. Stop timing when the Trail is completed, or when maximum time is reached (150 seconds 2.5 min). ![]() ![]() Start timing as soon as the instruction is given to begin. Background: The ecological validity of performance-based cognitive screeners needs to be tested in order for them to be fully recommended for use within clinical practice and research. Lack of timed measures of processing speed may explain the relative insensitivity of the MoCA and ACE-R to single nonmemory domain impairment. Test A: If Sample A is completed correctly, the administrator repeats the above instructions for Trails A.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |